Everolimus stent study for coronary artery disease
Part of Heart & circulation clinical trials.
This trial is testing a new stent coated with a medicine called everolimus to keep your heart arteries open. It may be an option if you have blockages that need a stent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old
- You have significant blockages in one or more heart arteries
- The blockages are in your native arteries or from stent re-narrowing
- Your artery size is between 2.0 and 4.5 mm
- The blockage is less than 48 mm long
- You are not pregnant, have no severe heart failure, and no allergies to the study drugs or metals
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a drug-coated heart stent (sirolimus with ascorbic acid, a form of vitamin C) works as well as another type (everolimus) for patients with blocked coronary arteries. Both drugs help prevent the stent from becoming blocked again.
This trial compares a newer type of stent (with very thin struts and a coating that dissolves) to a standard stent in people having a heart artery procedure. It aims to see if the new stent works as well or better.
This trial tests a new stent system for treating narrowed heart arteries. If you have coronary artery disease with one or two blockages that are at least 70% narrowed, this procedure might be an option for you.
This trial tests a stent that slowly dissolves after opening a blocked heart artery, releasing a drug to prevent reclogging. It may help people with narrowing in one or two spots that are not too hard or twisted.
This trial tests a longer-than-usual drug-coated stent (Orsiro Mission) for treating long blockages in heart arteries. It aims to see if the stent is safe and effective for people with coronary artery disease.
This study follows people who need a coronary (heart) stent to see how they do after treatment. It does not sound like an experimental drug trial for you—it’s mainly about collecting health information after a stent procedure.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.